3C

Description

The 3C Study is a randomized trial investigating different immunosuppression strategies in kidney transplantation. It recruited 852 participants between 2010 and 2013 and these participants are now under long-term follow-up through registries to allow the trial to assess the long-term risks and benefits of the different treatments. A key outcome is transplant function which is assessed from creatinine measurements done routinely as part of transplant care and collected by UKRR. These data are critical to the long-term assessments.

Who

Richard Haynes richardhaynes@nhs.net

Data Sharing Agreement

DSA71

Data Supplied

Creatinine (including date of sample or date of quarter in which result collected)

If available: tacrolimus, sirolimus levels (including date of sample or date of quarter in which result collected)

Current RRT modality

First dialysis modality following transplant (and date of start)